Content The Politics Behind the Pipeline: How MFN Pricing and Tariffs Are Reshaping Pharma’s Global Strategy 8 June 2026
Content MFN Drug Pricing: Industry Pushes Back as Biotech R&D Funding Hangs in the Balance 24 March 2026
Policy Briefing TrumpRx Launches: Will Direct-to-Consumer Platform Actually Lower Drug Costs? 6 February 2026
